Edwards Lifesciences Corporation
EW · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,170 | $1,402 | $1,522 | $1,503 |
| Dep. & Amort. | $155 | $145 | $140 | $135 |
| Deferred Tax | -$323 | -$272 | -$255 | -$41 |
| Stock-Based Comp. | $162 | $139 | $127 | $109 |
| Change in WC | -$259 | -$526 | -$421 | $145 |
| Other Non-Cash | -$3,362 | $8 | $106 | -$119 |
| Operating Cash Flow | $542 | $896 | $1,218 | $1,732 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$282 | -$266 | -$265 | -$330 |
| Net Acquisitions | -$1,062 | -$95 | $0 | $330 |
| Inv. Purchases | -$946 | -$106 | -$779 | -$1,892 |
| Inv. Sales/Matur. | $858 | $716 | $1,359 | $529 |
| Other Inv. Act. | $3,745 | -$75 | -$63 | -$359 |
| Investing Cash Flow | $2,313 | $174 | $252 | -$1,723 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | -$2 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,159 | -$880 | -$1,727 | -$513 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $176 | $169 | $143 | $158 |
| Financing Cash Flow | -$983 | -$711 | -$1,585 | -$356 |
| Forex Effect | $39 | $17 | $19 | $14 |
| Net Chg. in Cash | $1,911 | $375 | -$95 | -$333 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,148 | $773 | $867 | $1,200 |
| End Cash | $3,059 | $1,148 | $773 | $867 |
| Free Cash Flow | $290 | $630 | $953 | $1,402 |